Modifications to the Geriatric Nutritional Risk Index Predicts Complications After Total Joint Arthroplasty
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2024.12.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Brian K Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Tech Carilion School of Medicine, Roanoke, Virginia. Hauptthemen laut MEDLINE: Postoperative Complications, Nutrition Assessment, Geriatric Assessment, Malnutrition. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Preoperative malnutrition is a known risk factor for postoperative complications following total joint arthroplasty (TJA); however, there is scant literature comparing which nutritional index is best at predicting these outcomes. The purpose of this study was to investigate the utility of the Maastricht index, Onodera's Prognostic Nutritional Index, the Geriatric Nutritional Risk index, and a novel, modified Geriatric Nutritional Risk Index (mGNRI) in predicting periprosthetic joint infection (PJI), wound complications (WCs), readmission, and reoperation rates after TJA. METHODS: A single-center, retrospective cohort study was performed of patients who underwent primary TJA from January 2016 to December 2021. The 90-day preoperative albumin, prealbumin, and total lymphocyte count were collected. Outcome measures were PJI, WC, readmission, and return to the operating room. Youden's index (YI) and Receiver operator characteristic curves were used to determine optimal cutoff points. Multivariable logistic regression was used to adjust for potential confounders, including body mass index, age, and the Charlson comorbidity index. RESULTS: There were 1,575 patients included in the study. The mGNRI had the greatest accuracy (area under the curve = 0.633; optimal cutoff point = 92.8) in predicting postoperative adverse outcomes. Complication rates were significantly higher in the low mGNRI group (≤ 92.8). When controlled for body mass index, Charlson comorbidity index, and age, the odds of PJI, WC, readmission, and reoperation in patients who had low mGNRI were 6.61 (P = 0.005), 3.04 (P = 0.021), 2.25 (P = 0.020), and 2.75 (P = 0.024), respectively. CONCLUSIONS: The mGNRI is an easy-to-calculate nutritional index and an excellent predictor of postoperative complications following TJA. The mGNRI outperformed Geriatric Nutritional Risk index, Maastricht index, and Onodera's Prognostic Nutritional Index in predicting postoperative complications. Our results suggest that patients who fall below the mGNRI threshold of 92.8 should be carefully considered for nutritional optimization prior to TJA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Virginia Tech Carilion School of Medicine, Roanoke, Virginia.
- Department of Orthopaedic Surgery, Carilion Clinic Institute for Orthopaedics & Neurosciences, Roanoke, Virginia.
- Virginia Tech Carilion School of Medicine, Roanoke, Virginia; Department of Orthopaedic Surgery, Carilion Clinic Institute for Orthopaedics & Neurosciences, Roanoke, Virginia.
Zitieren
APA
Hansen, B. K., Pekas, D. R., Burks, G. W., Sandefur, E. P., Apel, P. J., & Adrados, M. (2025). Modifications to the Geriatric Nutritional Risk Index Predicts Complications After Total Joint Arthroplasty. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.12.027
Vancouver
Hansen BK, Pekas DR, Burks GW, Sandefur EP, Apel PJ, Adrados M. Modifications to the Geriatric Nutritional Risk Index Predicts Complications After Total Joint Arthroplasty. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2024.12.027
BibTeX
@article{Hansen2025,
author = {Hansen, Brian K and Pekas, Devon R and Burks, Garret W and Sandefur, Evan P and Apel, Peter J and Adrados, Murillo},
title = {Modifications to the Geriatric Nutritional Risk Index Predicts Complications After Total Joint Arthroplasty},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2024.12.027}
}
EUVIMED